Breaking News Instant updates and real-time market news.

DE

Deere

$117.19

-6.7905 (-5.48%)

, CPN

Calpine

$14.83

1.33 (9.85%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00

On The Fly: Top stock stories at midday

Stocks opened in negative territory under the weight of the Trump administration fallout and the terror situation in Spain. The market picked up downside momentum shortly after the open and pushed the Dow to a triple digit loss. In the second hour of trading, the market reversed with the Nasdaq and S&P making it back to positive ground and the Dow within striking distance. Oil prices are little changed but gold prices have crept higher and are now slightly below $1,300 an ounce. ECONOMIC NEWS: In the U.S., consumer sentiment sentiment surged 4.2 points to 97.6 in the August preliminary read from the University of Michigan survey, much better than expected. In addition, the U.S. QSS figures that track activity for the service sector revealed a 6.2% Q2 year-over-year gain in the aggregate "selected services" measure that was similar to last quarter's 6.3% gain. COMPANY NEWS: Shares of Deere & Company (DE) slipped 5.3% despite reporting better-than-expected quarterly earnings and raising its revenue guidance for fiscal 2017. Following the quarterly report, however, Baird analyst Mig Dobre downgraded the stock to Neutral from Outperform, citing quarterly results that were below his expectations as the pace of margin improvement lagged his forecast... On the other side, shares of Calpine (CPN) jumped 9.9% after it agreed to be acquired by Energy Capital Partners for $5.6B. Energy Capital, along with a consortium of investors led by Access Industries and Canada Pension Plan Investment Board, will acquire the company for $15.25 per share in cash, which represents a roughly 51% premium to Calpine's unaffected share price of $10.07 per share on May 9, 2017... Following early gains, Gap (GPS) shares were 1.2% lower at midday after the retailer reported better-than-expected quarterly results, including a 1% year-over-year gain in comparable sales for the quarter. The comapny also raised its adjusted earnings per share view for fiscal 2017. MAJOR MOVERS: Among the notable gainers were Ross Stores (ROST) and Applied Materials (AMAT), which rose 10.2% and 2.3%, respectively, after reporting quarterly results. Also higher was Tenet Healthcare (THC), which surged 12% after two of the company's directors announced their immediate resignation, citing "irreconcilable differences." Among the noteworthy losers was Infosys (INFY), which slipped 7.7% in New York after it announced the resignation of Vishal Sikka as chief executive officer. Commenting on the matter, the Infosys board said that founder N.R. Murthy's "continuous" attacks on the board and management drove Sikka's resignation. Also lower was Foot Locker (FL), which dropped 26.2% after reporting weaker-than-expected quarterly results. Shares of rival Finish Line (FINL) fell nearly 5% after the news. INDEXES: Near midday, the Dow was down 8.66, or 0.04%, to 21,742.07, the Nasdaq was up 23.31 or 0.38%, to 6,245.23, and the S&P 500 was up 4.41, or 0.18%, to 2,434.42.

DE

Deere

$117.19

-6.7905 (-5.48%)

CPN

Calpine

$14.83

1.33 (9.85%)

GPS

Gap

$22.43

-0.255 (-1.12%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

THC

Tenet

$14.04

1.385 (10.95%)

INFY

Infosys

$14.71

-1.22 (-7.66%)

FL

Foot Locker

$34.97

-12.73 (-26.69%)

FINL

Finish Line

$11.99

-0.17 (-1.40%)

  • 18

    Aug

  • 18

    Aug

  • 23

    Aug

  • 06

    Sep

  • 22

    Nov

DE Deere
$117.19

-6.7905 (-5.48%)

08/18/17
08/18/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) downgraded to Hold from Buy at Stifel WITH analyst Scott Devitt saying Blue Apron is facing challenges with the transition to its new fulfillment center in Linden, NJ while at the same time dealing with lower fulfillment efficiency/accuracy stemming from its recent broader product expansion. 2. PNM Resources (PNM) was downgraded to Sector Perform from Outperform at RBC Capital and to Neutral from Buy at Ladenburg. 3. Deere (DE) downgraded to Neutral from Outperform at Baird with analyst Mig Dobre citing third quarter results which were below his expectations as the pace of margin improvement lagged his forecast. 4. Foot Locker (FL) downgraded to Market Perform from Outperform at Telsey Advisory. 5. Brunswick (BC) downgraded to Neutral from Outperform at Wedbush with analyst James Hardiman citing July SSI data that was significantly worse than expected, which showed just 2% growth for the industry and a 3% decline for the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/17
BARD
08/18/17
DOWNGRADE
Target $130
BARD
Neutral
Deere downgraded to Neutral at Baird
As reported previously, Baird analyst Mig Dobre downgraded Deere to Neutral from Outperform. The analyst cited Q3 results which were below his expectations as the pace of margin improvement lagged his forecast. He noted the company raised guidance but he sees tougher comps and weak farm fundamentals as headwinds. Dobre lowered his price target to $130 from $140 on Deere shares.
08/18/17
BARD
08/18/17
DOWNGRADE
BARD
Neutral
Deere downgraded to Neutral from Outperform at Baird
08/15/17
08/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying he is cautious into the print given recent data and expects the pace of earnings performance relative to expectations to begin to subside. 2. Zynerba (ZYNE) was downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Jefferies. 3. Uniti Group (UNIT) downgraded to Neutral from Buy at BofA/Merrill with analyst David Barden saying Windstream's (WIN) dividend cut increases concerns about the health of the business and, combined with Uniti's increasing cost of capital, creates a negative feedback loop for the stock. 4. Farmland Partners (FPI) downgraded to Neutral from Outperform at Baird with the firm's analyst saying financial leverage is moving towards 18x EBITDA following the recent preferred offering, and the participating rights could create a liability for the common holders that could grow over time and a common dividend AFFO payout ratio over 130% estimated through YE19. 5. Banco Santander (SAN) downgraded to Neutral from Buy at Goldman Sachs with analyst Jose Abad seeing the valuation as full following the recent outperformance of the shares. The analyst lowered his price target for the shares to EUR 6.40. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CPN Calpine
$14.83

1.33 (9.85%)

07/06/17
SBSH
07/06/17
NO CHANGE
Target $15
SBSH
Buy
Citi sees increasing likelihood of PE deal for Calpine
Citi analyst Praful Mehta believes the likelihood is increasing for a private equity exit for Calpine. Management's refusal to talk about the deal suggests that the process and negotiations are continuing well, Mehta tells investors in a research note. The analyst continues to think that if a deal is announced, it is likely in the $15 range and over the next couple of months. He keeps a Buy rating on Calpine with a $15 price target.
05/24/17
FBCO
05/24/17
NO CHANGE
FBCO
Outperform
Exelon a net winner despite 'disappointing' 2020/21 auction, says Credit Suisse
Following PJM Interconnection's annual capacity auction, Credit Suisse analyst Michael Weinstein called Exelon a net winner despite "disappointing" RPM results for the 2020/21 capacity auction. The results for the EMAAC area should help drive a net positive result for Exelon assuming the same amount of capacity cleared year-over-year, he indicated. PSEG (PEG) and Calpine (CPN)are also "net beneficiaries," while Dynegy (DYN), NRG Energy (NRG) and FirstEnergy (FE) will "bear the brunt of a poor RTO showing," Weinstein tells investors.
06/20/17
SBSH
06/20/17
NO CHANGE
SBSH
Citi sees increasing likelihood of Vistra acquiring Dynegy
After hosting investor meetings with managements in Texas, Citi analyst Praful Mehta believes the likelihood of a Dynegy (DYN) acquisition by Vistra Energy (VST) is increasing. He views price as the "likely gating item" and continues to expect an $11-$12 per share buyout price for Dynegy in an all stock deal. Vistra management seems "more open to the deal than we originally interpreted," Mehta tells investors in a research note. The analyst also believes a private equity exit for Calpine (CPN) is increasing likely as the company continues with its reported sale process.
07/10/17
GSCO
07/10/17
DOWNGRADE
Target $14
GSCO
Neutral
Calpine downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Michael Lapides downgraded Calpine to Neutral citing recent share appreciation and maintained a $14 price target.
GPS Gap
$22.43

-0.255 (-1.12%)

08/18/17
UBSW
08/18/17
NO CHANGE
Target $23
UBSW
Sell
Gap beat expectations but downside risk remains, says UBS
UBS analyst Michael Binetti said Gap had solid Q2 results but he does not see signs of a sustainable earnings acceleration. The analyst sees downside risk from gross margins and SG&A pressure in the second half of the year but raised his estimates slightly due to the Q2 beat. Binetti reiterated his Sell rating and $23 price target on Gap shares.
07/14/17
JPMS
07/14/17
NO CHANGE
Target $27
JPMS
Neutral
Gap added to Analyst Focus List at JPMorgan
JPMorgan analyst Matthew Boss added Netural-rated Gap to his firm's Analyst Focus List and upped his price target for the shares to $27 from $26. Trading at four times EBITDA with a 4% dividend and 8% free cash flow yield, Gap's near-term risk/reward is "too hard to ignore," Boss tells investors in a research note. He calls the company his top Specialty Softlines idea through the end of 2017.
08/18/17
JEFF
08/18/17
NO CHANGE
Target $35
JEFF
Buy
Gap posted solid quarter in tough environment, says Jefferies
Jefferies analyst Randal Konik views Gap's Q2 results as solid amid a tough operating environment for retailers. The company's beat was high quality, with upside on comps and gross margin, Konik tells investors in a post-earnings research note. He notes Q2 was the third consecutive quarter of positive comps. The analyst reiterates a Buy rating on Gap with a $35 price target.
06/05/17
06/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post saying consensus estimates are achievable following the first quarter headline miss. The analyst sees improved quarterly net account adds ahead and improved execution driving shares higher. 2. Exxon Mobil (XOM) upgraded to Outperform from Sector Perform at Scotia Howard Weil with the firm saying recent weakness provides a buying opportunity for this defensive play within the oil patch. 3. eBay (EBAY) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Bieber assuming coverage on the stock while saying there are multiple paths to create value. 4. Gap (GPS) upgraded to Outperform from Perform at Oppenheimer with analyst Anna Andreeva saying the shares are down 17% from last month's highs despite the retailer posting 12% earnings growth in the first quarter. 5. Outfront Media (OUT) upgraded to Buy from Hold at Loop Capital with analyst David Miller saying he believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ROST Ross Stores
$53.33

-1.04 (-1.91%)

08/02/17
FBCO
08/02/17
NO CHANGE
Target $64
FBCO
Neutral
Ross Stores price target lowered to $64 from $70 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Ross Stores to $64 from $70 given the recent deceleration of returns and widened gap between the off-price group's share price versus the rest of the retail group. The analyst also notes that the company also continues to expand square footage. He reiterates a Neutral rating on the shares.
08/15/17
WELS
08/15/17
NO CHANGE
WELS
TJX results bode well for off-price sector, says Wells Fargo
Wells Fargo analyst Ike Boruchow says that TJX's (TJX) better than expected Q2 results bode well for the off-price retail sector. The analyst notes that the company's merchandise margins rebounded in Q2, even though its overall gross margins came in below expectations due to "losses on inventory hedges," Other companies in the sector include Ross Stores, (ROST) and Burlington Stores (BURL). The analyst keeps Outperform ratings on all three stocks.
08/18/17
WELS
08/18/17
NO CHANGE
WELS
Ross Stores reported 'very solid' Q2 results, says Wells Fargo
Wells Fargo says that Ross Stores reported "very solid" Q2 results "with no holes to poke at." " Wells thinks that the company dispelled investors' concerns, partly because its comp sales came in above expectations and it increased its merchant margins,. Wells keeps an Outperform rating on the shares.
08/18/17
RHCO
08/18/17
NO CHANGE
RHCO
Ross Stores should be bought into strength, says SunTrust
SunTrust analyst Pamela Quintiliano says that Ross Stores reported "very strong" Q2 results and continues to execute well. She thinks the company is well-positioned to continue to outperform and recommends buying the shares on strength.
AMAT Applied Materials
$43.12

-1.34 (-3.01%)

08/15/17
RBCM
08/15/17
NO CHANGE
RBCM
Applied Materials results should beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani, predicts that Applied Materials' (AMAT) July quarter results will beat expectations, while its September quarter guidance will also come in above expectations. The analyst says that the company's peer, Lam Research (LRCX), reported "solid" June quarter results and provided September quarter guidance that came in "well above" expectations. The analyst keeps a Sector Perform rating on Applied Materials.
08/18/17
CHLM
08/18/17
NO CHANGE
Target $60
CHLM
Buy
Applied Materials price target raised to $60 from $53 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for Applied Materials to $60 citing the company's better than expected results and guidance. With WFE spending levels continuing to improve, and memory markets remaining healthy, Applied Materials' outlook "remains fabulous," Schwab tells investors in a post-earnings research note. He reiterates a Buy rating on the shares.
08/18/17
STFL
08/18/17
NO CHANGE
STFL
Applied Materials price target raised to $61 from $55 at Stifel
Stifel analyst Patrick Ho raised his price target on Applied Materials after the company reported results he called "stellar." The analyst believes that the company's comments indicate that it could have another "record year" in 2018. Ho raised his price target on the shares to $61 from $55 and reiterates a Buy rating.
08/18/17
FBCO
08/18/17
NO CHANGE
Target $62
FBCO
Outperform
Applied Materials price target raised to $62 from $54 at Credit Suisse
Credit Suisse analyst Farhan Ahmad raised his price target for Applied Materials to $62 saying the company beat Street estimates for Q4 and guided to above estimates. The company is showing more consistent growth, delivering margin expansion, and reducing share count, Ahmad tells investors in a post-earnings research note. He expects the stock's valuation multiples to expand as "investors start to realize the consistency of growth." The analyst keeps an Outperform rating on Applied Materials.
THC Tenet
$14.04

1.385 (10.95%)

08/08/17
BARD
08/08/17
NO CHANGE
Target $23
BARD
Outperform
Tenet results better than they appear, says Baird
Baird analyst Whit Mayo said the Q2 results for Tenet were better than they appeared. He admitted the optics of the print, guidance and complexity overshadowed the company's progress, but he noted Tenet's acute core growth outpaces all peers and half of the guide down came from its Houston sale. Mayo maintained his Outperform rating and $23 price target on Tenet shares.
08/09/17
BARD
08/09/17
NO CHANGE
Target $23
BARD
Outperform
Tenet shares 'feel' oversold, says Baird
Baird analyst Whit Mayo believes Tenet shares "feel" oversold, but he admits there is no clear catalyst soon. He said the current environment is tough and Q3 is historically not a time to be overweight medical providers, but the company has made some real progress on a turnaround. Mayo maintained his Outperform rating and $23 price target on Tenet shares.
08/16/17
PIPR
08/16/17
NO CHANGE
PIPR
Piper 'incrementally more bearish' on Hospital sector
Valuations in the Hospital sector have come in, but not enough, Piper Jaffray analyst Sarah James tells investors in a research note. She believes that contradictory to what the hospitals are suggesting, structural headwinds will continue for five-plus years. The analyst believes the group should be trading at a discount. James has an Underweight rating on Community Health Systems (CYH), Overweight ratings on HCA Holdings (HCA) and Universal Health (UHS), and Neutral ratings on LifePoint (LPNT) and Tenet (THC).
08/18/17
LEER
08/18/17
NO CHANGE
Target $23
LEER
Outperform
Tenet post-earnings selloff overdone, says Leerink
Leerink analyst Ana Gupte views the post-Q2 earnings selloff in shares of Tenet Healthcare as overdone. While the company experienced the same secular headwinds in the Hospital segment as its peers, the pricing growth was "solid" and the Ambulatory segment performed well with increased guidance, Gupte tells investors in a research note. She sees Tenet's ability to achieve earnings expectations as better than feared and keeps an Outperform rating on the name. Gupte dropped her price target for the shares to $23 from $27.
INFY Infosys
$14.71

-1.22 (-7.66%)

04/13/17
04/13/17
DOWNGRADE

Underperform
Infosys downgraded on core business, pricing pressures at William Blair
As previously reported, William Blair downgraded Infosys to Underperform from Market Perform following the earnings report. Analyst Anil Doradla believes the core business will continue to be challenged due to commoditized solutions, margins will be pressured from legacy solutions that are facing pricing pressures, and questions the effectiveness of management's strategic direction and lack of focus on a total capital return strategy.
06/08/17
06/08/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoNation (AN) upgraded to Buy from Neutral at Northcoast. 2. Kite Pharma (KITE) upgraded to Buy from Neutral at BTIG with analyst Dane Leone saying data from Novartis (NVS) and Juno (JUNO) have failed to deliver any recognizable differentiation, though Leone gives Kite "a clear win" for the manufacturing of Axi-Cel versus peers. 3. Infosys (INFY) upgraded to Buy from Hold at HSBC with analyst Yogesh Aggarwal citing "undemanding" valuation and low expectations. 4. DSW (DSW) upgraded to Neutral from Underperform at Cleveland Research. 5. BHP Billiton (BHP) upgraded to Buy from Neutral at UBS with analyst Glyn Lawcock citing its current valuation, attractive yield, and upcoming catalysts that include asset disposals, approval of the attractive Spence Growth Option, and expectations for a new chairman in the near-term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/17
HSBC
06/08/17
UPGRADE
HSBC
Buy
Infosys upgraded to Buy from Hold at HSBC
HSBC analyst Yogesh Aggarwal upgraded Infosys to Buy citing "undemanding" valuation and low expectations.
04/17/17
RHCO
04/17/17
NO CHANGE
RHCO
Cognizant should be bought on weakness, says SunTrust
SunTrust analyst Frank Atkins recommends buying Cognizant (CTSH) on weakness after its peer, Infosys (INFY), reported roughly in-line results that Atkins called "underwhelming." Atkins says that Cognizant has greater exposure to the financial services and healthcare verticals, while Cognizant's removal of the cap on its operating margin should enable its profitability to increase.
FL Foot Locker
$34.97

-12.73 (-26.69%)

08/18/17
LEHM
08/18/17
NO CHANGE
Target $50
LEHM
Overweight
Foot Locker comp outlook likely viewed as realistic, says Barclays
Barclays analyst Matthew McClintock cut his price target for Foot Locker to $50 from $80 post today's results but keeps an Overweight rating on the shares. He believes most investors will views today's second half comp guidance of down 3% to down 4% as realistic. When combined with Foot Locker's efforts to reduce expenses, this should "soften the blow" to both earnings and valuation multiple downside, McClintock tells investors in a research note.
08/18/17
JPMS
08/18/17
DOWNGRADE
JPMS
Neutral
Foot Locker downgraded to Neutral from Overweight at JPMorgan
08/18/17
PIPR
08/18/17
NO CHANGE
Target $35
PIPR
Neutral
Foot Locker price target lowered to $35 from $60 at Piper Jaffray
Piper Jaffray analyst Erinn Murphy lowered her price target for Foot Locker (FL) to $35 and reduced her estimates "materially" following the company's Q2 miss and guide down. Management referred to the rapidly changing landscape as some of the most significant shifts seen in history, Murphy points out in a research note. She sees the shift to more digital platforms as well as the brand leadership rotation from Nike (NKE) to adidas (ADDYY) as weighing on Foot Locker's traffic and margins. The analyst keeps a Neutral rating on the shares.
08/18/17
WELS
08/18/17
DOWNGRADE
Target $37
WELS
Market Perform
Wells doubts investors will step into Foot Locker , downgrades shares
Wells Fargo analyst Tom Nikic downgraded Foot Locker to Market Perform from Outperform and cut his price target for the shares to $37 from $55 saying company's Q2 performance was "far worse than expected." The analyst doubts investors will look to buy today's post-earnings selloff given the concerns around decelerating trends across the athletic space. Deutsche Bank and Telsey Advisory also downgraded Foot Locker today.
FINL Finish Line
$11.99

-0.17 (-1.40%)

08/18/17
SBSH
08/18/17
NO CHANGE
Target $81
SBSH
Buy
Foot Locker results and guidance 'greatly disappoints,' says Citi
Citi analyst Kate McShane says Foot Locker's (FL) Q2 results and outlook "greatly disappoints." The company posted its first negative comp since Q4 of 2009, McShane tells investors in a post-earnings research note. Along with Foot Locker, the analyst expects weakness in shares of Nike (NKE) and Finish Line (FINL) as well as Under Armour (UAA, UA) and Dick's Sporting Goods (DKS). McShane currently has a Buy rating on Foot Locker.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $52
FBCO
Neutral
Foot Locker price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Foot Locker (FL) to $52 from $66 given increasing industry headwinds and following disappointing commentary by peers Finish Line (FINL) and Hibbett Sports (HIBB). The analyst believes the best-in-class execution by Foot Locker may no longer be enough. He reiterates a Neutral rating on Foot Locker's shares.
07/24/17
RAJA
07/24/17
NO CHANGE
RAJA
Market Perform
Hibbett warning has negative read-through for Under Armour, says Raymond James
Raymond James analyst Dan Wewer noted that Hibbett Sports' (HIBB) same-store sales warning follows Finish Line's (FINL) Q1 release on June 23 that May sales suffered from weak consumer traffic and difficult product launch comparisons. The read through is negative for Hibbett's vendors, including Under Armour (UAA), said Wewer, who added that it also appears negative for Dick's Sporting Goods (DKS), though he is not sure if Hibbett's sales trends were company specific or reflective of the industry.
05/22/17
05/22/17
UPGRADE
Target $17

Buy
Finish Line upgraded to Buy on valuation at Monness Crespi
As previously reported, Monness Crespi upgraded Finish Line to Buy from Neutral with a $17 price target. Analyst Jjim Chartier said shares appear "cheap" and said he does not see risk to near-term sales or earnings. The analyst said athletic footwear trends are moving towards running, which is a tailwind for Finish Line, and the company has further cost savings opportunities.

TODAY'S FREE FLY STORIES

CELC

Celcuity

20:34
09/19/17
09/19
20:34
09/19/17
20:34
Syndicate
Celcuity 2.4M share IPO priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

BSTI

BEST Inc

20:33
09/19/17
09/19
20:33
09/19/17
20:33
Syndicate
Best Inc 45M share IPO priced at $10.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

20:25
09/19/17
09/19
20:25
09/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PCRX

Pacira

$35.70

-0.6 (-1.65%)

20:00
09/19/17
09/19
20:00
09/19/17
20:00
Recommendations
Pacira analyst commentary at BMO Capital »

Pacira's Exparel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AVEVF

Aveva

19:56
09/19/17
09/19
19:56
09/19/17
19:56
Upgrade
Aveva rating change at Goldman Sachs »

Aveva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

18:58
09/19/17
09/19
18:58
09/19/17
18:58
Syndicate
Zai Lab announces upsizing of U.S. IPO of American depositary shares »

Zai Lab announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated at Cantor »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated at KeyBanc »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.